Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series
Cancer Medicine · 2024-07 · 13 (13)
DOI: 10.1002/cam4.7367 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer Medicine, online erschienen am 05.07.2024. Verfasst von Angel Calvo Tudela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Virgen de la Victoria University Hospital, Malaga, Spain. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The ‘FAST‐forward’, study published in April 2020, demonstrated the effectiveness of an extremely hypofractionated radiotherapy schedule, delivering the total radiation dose in five sessions over the course of 1 week. We share our department's experience regarding patients treated with this regimen in real‐world clinical settings, detailing outcomes related to short‐term toxicity and efficacy.
Methods
A descriptive observational study was conducted on 160 patients diagnosed with breast cancer. Between July 2020 and December 2021, patients underwent conservative surgery followed by a regimen of 26 Gy administered in five daily fractions.
Results
The median age was 64 years (range: 43–83), with 82 patients (51.3%) treated for left‐sided breast cancer, 77 patients (48.1%) for right‐sided breast cancer, and 1 instance (0.6%) of bilateral breast cancer. Of these, 66 patients had pT1c (41.3%), 70.6% were infiltrative ductal carcinomas, and 11.3% were ductal carcinoma in situ. Most tumours exhibited intermediate grade (41.9%), were hormone receptor positive (81.3%), had low Ki‐67 (Ki‐67 < 20%; 51.9%) and were Her 2 negative (85%). The majority of surgical margins were negative (99.4%). Among the patients, 72.5% received hormonotherapy, and 23.8% received chemotherapy. Additionally, 26 patients (16.3%) received an additional tumour boost following whole breast irradiation (WHBI) of 10 Gy administered in five sessions of 2 Gy over a week. The median planning target volume (PTV) was 899 cm 3 (range: 110–2509 cm 3 ). Early toxicity was primarily grade I radiodermatitis, affecting 117 patients (73.1%). During a median follow‐up of 15 months (range: 3.9–28.77), only one patient experienced a local relapse, which required mastectomy.
Conclusions
The implementation of this highly hypofractionated regimen in early‐stage breast cancer appears feasible and demonstrates minimal early toxicity. However, a more extended follow‐up duration would be required to evaluate long‐term toxicity and efficacy accurately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Virgen de la Victoria University Hospital, Malaga, Spain.
- Malaga Biomedical Research Institute, Malaga, Spain.
ORCID-Profile: María Jesús García Anaya
Zitieren
APA
Calvo Tudela, A., García Anaya, M. J., Segado Guillot, S., Martin Romero, N., Lorca Ocón, M. J., Medina Carmona, J. A., Gómez-Millán, J., & García Ríos, I. (2024). Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series. Cancer Medicine, 13(13). https://doi.org/10.1002/cam4.7367
Vancouver
Calvo Tudela A, García Anaya MJ, Segado Guillot S, Martin Romero N, Lorca Ocón MJ, Medina Carmona JA, et al. Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series. Cancer Medicine. 2024;13(13). doi:10.1002/cam4.7367
BibTeX
@article{CalvoTudela2024,
author = {Calvo Tudela, Angel and García Anaya, María Jesús and Segado Guillot, Salvador and Martin Romero, Nuria and Lorca Ocón, María Jesús and Medina Carmona, José Antonio and Gómez-Millán, Jaime and García Ríos, Isabel},
title = {Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {13},
doi = {10.1002/cam4.7367}
}
EUVIMED